Trial Details

RECRUITING
Basic Information
Clinical ID c481
Identifier NCT06553547
Trial Title 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Constipation (IBS-C)
Interventions DRUG: Tenapanor|DRUG: Placebo
Participant Information
Sponsor Ardelyx
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2024-07-24
Primary Completion Date 2026-06
Completion Date 2026-06